(PUB) Publicis e - Overview
Sector: Communication Services | Industry: Advertising Agencies | Exchange: PA (France) | Market Cap: 17.868m EUR | Total Return: -6.9% in 12m
Industry Rotation: -35.4
Avg Turnover: 58.5M EUR
Peers RS (IBD): 46.4
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Publicis Groupe S.A. (ticker PUB) is a global leader in marketing, communications, and digital transformation, operating across North America, Europe, Asia-Pacific, Latin America, Africa, and the Middle East. Its portfolio includes Publicis Communications, Publicis Sapient, Publicis Media, Publicis Health, and specialized healthcare communication services, all built around the “Power of One” integrated model.
In FY 2025 the group generated €13.2 billion in revenue, a 5.4 % year-over-year increase driven by strong growth in digital services (+9 % YoY) and a 12 % rise in programmatic media spend. Operating margin expanded to 12.8 % as cost-efficiency initiatives took hold, while the return on equity reached 15.2 %. The advertising sector is being propelled by the continued shift to data-driven, AI-enabled campaigns and the projected global programmatic ad spend surpassing $200 billion in 2025.
For a deeper dive into Publicis’s valuation and outlook, you might explore the latest analysis on ValueRay.
- Global advertising spending impacts agency revenue
- Digital transformation services drive new client acquisition
- Economic downturns reduce marketing budgets
- Data privacy regulations increase operational costs
| Net Income: 2.74b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 3.91 > 1.0 |
| NWC/Revenue: -2.94% < 20% (prev -8.88%; Δ 5.94% < -1%) |
| CFO/TA 0.13 > 3% & CFO 5.33b > Net Income 2.74b |
| Net Debt (1.63b) to EBITDA (5.21b): 0.31 < 3 |
| Current Ratio: 0.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (253.4m) vs 12m ago 0.04% < -2% |
| Gross Margin: 21.54% > 18% (prev 0.26%; Δ 2.13k% > 0.5%) |
| Asset Turnover: 73.86% > 50% (prev 72.40%; Δ 1.46% > 0%) |
| Interest Coverage Ratio: 15.87 > 6 (EBITDA TTM 5.21b / Interest Expense TTM 254.5m) |
| A: -0.02 (Total Current Assets 23.07b - Total Current Liabilities 23.89b) / Total Assets 40.01b |
| B: 0.20 (Retained Earnings 8.08b / Total Assets 40.01b) |
| C: 0.11 (EBIT TTM 4.04b / Avg Total Assets 37.96b) |
| D: 0.24 (Book Value of Equity 7.16b / Total Liabilities 29.59b) |
| Altman-Z'' Score: 1.49 = BB |
| DSRI: 1.11 (Receivables 17.72b/14.74b, Revenue 28.04b/26.00b) |
| GMI: 1.23 (GM 21.54% / 26.41%) |
| AQI: 0.93 (AQ_t 0.37 / AQ_t-1 0.40) |
| SGI: 1.08 (Revenue 28.04b / 26.00b) |
| TATA: -0.06 (NI 2.74b - CFO 5.33b) / TA 40.01b) |
| Beneish M-Score: -2.78 (Cap -4..+1) = A |
Over the past week, the price has changed by +0.30%, over one month by -1.68%, over three months by -15.98% and over the past year by -6.93%.
| Analysts Target Price | - | - |
P/E Trailing = 11.0123
P/E Forward = 8.7184
P/S = 1.027
P/B = 1.7239
P/EG = 2.0396
Revenue TTM = 28.04b EUR
EBIT TTM = 4.04b EUR
EBITDA TTM = 5.21b EUR
Long Term Debt = 3.08b EUR (from longTermDebt, last quarter)
Short Term Debt = 760.0m EUR (from shortTermDebt, last quarter)
Debt = 5.66b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.63b EUR (from netDebt column, last quarter)
Enterprise Value = 19.33b EUR (17.87b + Debt 5.66b - CCE 4.20b)
Interest Coverage Ratio = 15.87 (Ebit TTM 4.04b / Interest Expense TTM 254.5m)
EV/FCF = 4.00x (Enterprise Value 19.33b / FCF TTM 4.84b)
FCF Yield = 25.03% (FCF TTM 4.84b / Enterprise Value 19.33b)
FCF Margin = 17.25% (FCF TTM 4.84b / Revenue TTM 28.04b)
Net Margin = 9.78% (Net Income TTM 2.74b / Revenue TTM 28.04b)
Gross Margin = 21.54% ((Revenue TTM 28.04b - Cost of Revenue TTM 22.00b) / Revenue TTM)
Gross Margin QoQ = 13.87% (prev 14.13%)
Tobins Q-Ratio = 0.48 (Enterprise Value 19.33b / Total Assets 40.01b)
Interest Expense / Debt = 0.23% (Interest Expense 13.0m / Debt 5.66b)
Taxrate = 27.28% (311.0m / 1.14b)
NOPAT = 2.94b (EBIT 4.04b * (1 - 27.28%))
Current Ratio = 0.97 (Total Current Assets 23.07b / Total Current Liabilities 23.89b)
Debt / Equity = 0.54 (Debt 5.66b / totalStockholderEquity, last quarter 10.45b)
Debt / EBITDA = 0.31 (Net Debt 1.63b / EBITDA 5.21b)
Debt / FCF = 0.34 (Net Debt 1.63b / FCF TTM 4.84b)
Total Stockholder Equity = 10.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.22% (Net Income 2.74b / Total Assets 40.01b)
RoE = 26.71% (Net Income TTM 2.74b / Total Stockholder Equity 10.26b)
RoCE = 30.26% (EBIT 4.04b / Capital Employed (Equity 10.26b + L.T.Debt 3.08b))
RoIC = 21.74% (NOPAT 2.94b / Invested Capital 13.51b)
WACC = 5.97% (E(17.87b)/V(23.53b) * Re(7.81%) + D(5.66b)/V(23.53b) * Rd(0.23%) * (1-Tc(0.27)))
Discount Rate = 7.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -33.33 | Cagr: -0.18%
[DCF] Terminal Value 88.44% ; FCFF base≈4.08b ; Y1≈5.03b ; Y5≈8.58b
[DCF] Fair Price = 995.6 (EV 249.02b - Net Debt 1.63b = Equity 247.39b / Shares 248.5m; r=6.0% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 1.33 | EPS CAGR: -51.43% | SUE: 0.0 | # QB: 0
Revenue Correlation: 41.67 | Revenue CAGR: 39.99% | SUE: 0.94 | # QB: 2
EPS current Year (2026-12-31): EPS=7.84 | Chg7d=+0.013 | Chg30d=+0.013 | Revisions Net=+2 | Growth EPS=+4.8% | Growth Revenue=+3.2%
EPS next Year (2027-12-31): EPS=8.40 | Chg7d=+0.011 | Chg30d=+0.011 | Revisions Net=+1 | Growth EPS=+7.1% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -1.2% (Discount Rate 7.9% - Earnings Yield 9.1%)
[Growth] Growth Spread = +6.2% (Analyst 5.1% - Implied -1.2%)